Imipenem And Cilastatin Injection, Powder, For Solution
Product Images NDC 63323-349

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Imipenem And Cilastatin (NDC 63323-349). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imipenem Structural Formula (Nov0c 0001 01)

Chemical structure of Imipenem and Cilastatin Sodium, showing the molecular arrangement including rings, hydroxyl, carboxyl, and amide groups, as well as a water molecule (H2O) associated with the compound.*

FDA Label Image

Cilastatin Sodium Structural Formula (Nov0c 0001 02)

Chemical structure diagram of Imipenem and Cilastatin Sodium, showing the molecular composition and bonding arrangement of the active ingredients in this drug product.*

FDA Label Image

Figure (Nov0c 0002 03)

FDA Label Image

Vial (Nov0c 0002 04)

Label for Imipenem and Cilastatin for Injection, USP intravenous powder for solution, 250 mg/250 mg per vial. The label indicates this is a single-dose vial, not for direct infusion, for IV use only. It is labeled by Fresenius Kabi USA, LLC and includes storage instructions and barcode.*

FDA Label Image

Carton (Nov0c 0002 05)

Packaging label for Imipenem and Cilastatin Injection USP (I.V.) powder for solution with a strength of 250 mg/250 mg per vial. The label states it is for intravenous use only and not to be divided or used for direct infusion. The labeler is Fresenius Kabi USA, LLC, featuring product details including inactive ingredients and cautions for use.*

FDA Label Image

Vial (Nov0c 0002 06)

Label for Imipenem and Cilastatin Injection, USP (I.V.) 500 mg/500 mg per vial, a single-dose powder for solution intravenous injection by Fresenius Kabi USA, LLC. The label includes storage instructions, caution that it is not for direct infusion, and details on vial contents including the equivalent of imipenem and cilastatin sodium.*

FDA Label Image

Carton (Nov0c 0002 07)

Imipenem and Cilastatin for Injection, USP (I.V.) 500 mg/500 mg per vial packaging label. The label indicates the product is for intravenous use only, supplied by Fresenius Kabi USA, LLC under the brand name Novaplus. It includes dosing caution for single-dose vials and specifies imipenem and cilastatin sodium as active ingredients in powder form for solution.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.